levodopa has been researched along with Alzheimer Disease in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (22.41) | 18.7374 |
| 1990's | 15 (25.86) | 18.2507 |
| 2000's | 12 (20.69) | 29.6817 |
| 2010's | 11 (18.97) | 24.3611 |
| 2020's | 7 (12.07) | 2.80 |
| Authors | Studies |
|---|---|
| Leitinger, G; Maurer, C; Radulović, S; Sunkara, S | 1 |
| D'Amelio, M; Giacalone, E; Keller, F; Krashia, P; La Barbera, L; Lupascu, CA; Migliore, M; Nobili, A; Renzi, M; Spoleti, E | 1 |
| Araki, T; Furusho, T; Ito, M; Kobayashi, S; Kogure, S; Konishi, F; Soeda, Y; Takashima, A; Takekoshi, S; Yamauchi, J | 1 |
| Dube, T; Kour, A; Kumar, A; Panda, JJ | 1 |
| Komatsu, K; Takahashi, M; Ueda, A | 1 |
| Conn, PJ; Di Menna, L; Dogra, S; Iacovelli, L; Joffe, ME; Nicoletti, F; Orlando, R; Zuena, AR | 1 |
| Je, NK; Ku, M | 1 |
| Artamonova, A; Hayes, KC; Koledova, VV; Rha, C; Sambanthamurthi, R; Schneider, K; Sinskey, AJ; Subramaniam, A; Weinberg, RP | 1 |
| Govindaraju, T; Khare, H; Makam, P; Rajasekhar, K; Ramakumar, S; Ramesh, M; Voshavar, C | 1 |
| Cho, JW; Cho, SH; Jang, H; Jo, H; Jung, YH; Kim, HJ; Kim, J; Kim, M; Kim, SJ; Na, DL; Park, JE; Park, S; Seo, SW | 1 |
| Hagiwara, M; Kasahata, N; Kato, H; Nakamura, A; Uchihara, T | 1 |
| Barrou, Z; Boddaert, J; Dieudonné, B; Faucounau, V; Greffard, S; Habert, MO; Verny, M | 1 |
| Brigo, F; Golaszewski, S; Höller, Y; Kunz, AB; Lochner, P; Nardone, R; Thomschewski, A; Trinka, E | 1 |
| Kwak, YT; Yang, Y | 1 |
| Agarwal, S; Arora, N; Devi, CS; Mittal, N; Mohanasrinivasan, V; Priyadoss, CG; Saxena, S; Singh, B | 1 |
| Bernardi, G; Esposito, Z; Martorana, A; Palmieri, MG; Pierantozzi, M; Sancesario, G; Stefani, A | 1 |
| Bernardi, G; Codecà, C; Esposito, Z; Koch, G; Kusayanagi, H; Martorana, A; Monteleone, F; Mori, F; Sancesario, G | 1 |
| Ngamreungphong, S; Nugent, K; Singhatiraj, E | 1 |
| Bernardi, G; Codecà, C; Di Lorenzo, F; Esposito, Z; Koch, G; Kusayanagi, H; Martorana, A; Monteleone, F; Mori, F | 1 |
| Wurtman, RJ | 1 |
| Bobkova, NV; Bondarenko, NA; Gudasheva, TA; Ostrovskaya, RU; Retyunskaya, MV; Samokhin, AN | 1 |
| Blau, N; Friberg, L; Hertz, JM; Hjermind, LE; Johannsen, LG; Lucking, CB; Nielsen, JE; Regeur, L; Sørensen, SA; Wevers, RA | 1 |
| Bottiglieri, T; Diaz-Arrastia, R; Greenberg, SM; Growdon, JH; Gurol, ME; Hyman, BT; Irizarry, MC; Locascio, JJ; Raju, S; Tennis, M | 1 |
| Brundin, P; Popovic, N | 1 |
| Bancher, C; Dal-Bianco, P; Jellinger, K; Katzenschlager, R; Poewe, W; Ransmayr, G; Schmidt, R; Wenning, G | 1 |
| Ambrée, O; de Souza Silva, MA; Dere, E; Herring, A; Keyvani, K; Lewejohann, L; Paulus, W; Richter, H; Sachser, N; Schäbitz, WR | 1 |
| Gardoni, F | 1 |
| MacDonald, E; Rekonen, M; Riekkinen, PJ; Soininen, H | 1 |
| Johnson, RT; Price, DL | 1 |
| Bliwise, DL; Hughes, M; Irbe, D; Rye, DB; Watts, N; Watts, RL | 1 |
| Corey-Bloom, J; Galasko, D; Olichney, JM; Thal, LJ | 1 |
| Coakley, D; Feely, J; O'Mahony, D; O'Neill, D; Rowan, M; Walsh, JB | 1 |
| Walsh, TJ | 1 |
| Knoll, J | 1 |
| Chandra, V; Korczyn, AD; Treves, TA | 1 |
| Daniel, SE; Hughes, AJ; Lees, AJ | 1 |
| Blankson, S; Daniel, SE; Hughes, AJ; Lees, AJ | 1 |
| Lieberman, A | 1 |
| Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
| Gwinn-Hardy, K; Hardy, J | 1 |
| Franceschi, C; Galeazzi, L; Giunta, S; Ronchi, P; Valli, B | 1 |
| Gniekowski, F | 1 |
| Danysz, W | 1 |
| Danielczyk, W | 1 |
| Kovács, A | 1 |
| Lannon, MC; Ott, BR | 1 |
| Bordet, R; Destée, A | 1 |
| Da Prada, M | 1 |
| Ericsson, K; Forssell, LG; Hellström, A; Winblad, B | 1 |
| Leathwood, PD | 1 |
| Escalona-Zapata, J; Giménez-Roldán, S; Mateo, D | 1 |
| Fujita, M; Shimizu, T | 1 |
| Leicester, J; Morris, J; Pamphlett, R | 1 |
| Como, P; Kurlan, R | 1 |
| Gottfries, CG | 1 |
| Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
| Kameyama, M; Kato, T | 1 |
| Fujita, M; Kuroda, K; Motomura, N; Shimizu, T; Toyoda, K | 1 |
15 review(s) available for levodopa and Alzheimer Disease
| Article | Year |
|---|---|
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine | 2021 |
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders.
Topics: Alzheimer Disease; Basal Ganglia; Humans; Levodopa; Parkinson Disease; Receptor, Metabotropic Glutamate 5 | 2023 |
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Brain; Delayed-Action Preparations; Diffusion; Disease Models, Animal; Drug Carriers; Drug Stability; Humans; Huntington Disease; Levodopa; Microspheres; Nerve Growth Factor; Neurodegenerative Diseases; Neuroprotective Agents; Parkinsonian Disorders; Polymers; Solubility | 2006 |
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Chronic Disease; Disks Large Homolog 4 Protein; Dyskinesia, Drug-Induced; Glutamic Acid; Guanylate Kinases; Humans; Huntington Disease; Intracellular Signaling Peptides and Proteins; Levodopa; Membrane Proteins; Pain; Protein Subunits; Receptors, N-Methyl-D-Aspartate; Stroke; Synapses | 2008 |
The spectrum of diseases with diffuse Lewy bodies.
Topics: Age Factors; Alzheimer Disease; Basal Ganglia Diseases; Cerebral Cortex; Dementia; Humans; Levodopa; Lewy Bodies | 1995 |
Site-specific pharmacology for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Cerebral Cortex; Flumazenil; Hippocampus; Humans; Levodopa; Neurons; Parkinson Disease | 1993 |
The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
Topics: Aging; Alzheimer Disease; Animals; Avoidance Learning; Catalase; Corpus Striatum; Drug Therapy, Combination; Learning; Levodopa; Male; Neurons; Parkinson Disease; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase | 1993 |
Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects.
Topics: Age Factors; Aged; Alzheimer Disease; Female; Humans; Incidence; Levodopa; Male; Morbidity; Parkinson Disease; Prevalence | 1993 |
Treatment of Parkinson's disease.
Topics: Alzheimer Disease; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Neurons; Parkinson Disease; Receptors, Dopamine; Selegiline | 1993 |
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Levodopa; Nerve Growth Factor; Neuroprotective Agents; Nicotine; Parkinson Disease | 2001 |
["Widening horizons" in the clinical application of selegiline].
Topics: Alzheimer Disease; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Selegiline | 1992 |
[From Parkinson's disease to Lewy body disease].
Topics: Alzheimer Disease; Dementia; Depressive Disorder; Humans; Levodopa; Lewy Bodies; Parkinson Disease | 1992 |
New approaches to the treatment of age-related brain disorders.
Topics: Aging; Alzheimer Disease; Benserazide; Benzophenones; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Levodopa; Monoamine Oxidase Inhibitors; Nitrophenols; Parkinson Disease; Picolinic Acids; Tolcapone | 1991 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
[Therapy of dementia in the aged].
Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Central Nervous System Diseases; Dementia; Humans; Levodopa; Middle Aged; Parasympathomimetics; Psychotropic Drugs; Rats; Synapses | 1985 |
2 trial(s) available for levodopa and Alzheimer Disease
| Article | Year |
|---|---|
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients.
Topics: Acetylcholine; Aged; Alzheimer Disease; Cerebral Cortex; Dopamine; Dopamine Agents; Electric Stimulation; Humans; Levodopa; Neural Inhibition; Neuropsychological Tests; Reaction Time; Statistics as Topic; Time Factors; Transcranial Magnetic Stimulation | 2009 |
Early stages of late onset Alzheimer's disease. Diagnostic criteria, protein metabolism, precursor loading effects, neurochemical and neuropsychological applications.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Nerve Tissue Proteins; Neuropsychological Tests; Neurotransmitter Agents; Phosphatidylcholines; Tryptophan | 1989 |
41 other study(ies) available for levodopa and Alzheimer Disease
| Article | Year |
|---|---|
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.
Topics: Action Potentials; Aging; Alzheimer Disease; Animals; CA1 Region, Hippocampal; Dopamine Agents; Dopaminergic Neurons; Electrophysiological Phenomena; Female; Levodopa; Male; Mice; Mice, Transgenic; Potassium Channels; Pyramidal Cells; Sodium Channels; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2022 |
Administration of mucuna beans (Mucuna pruriences (L.) DC. var. utilis) improves cognition and neuropathology of 3 × Tg-AD mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain Chemistry; Cognition; Diet; Disease Models, Animal; Female; Levodopa; Mice, Transgenic; Mucuna; tau Proteins | 2022 |
Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Gold; Humans; Levodopa; Peptide Fragments; Phenylalanine | 2022 |
[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Levodopa; Male; Movement Disorders; Piperidines; Posture | 2023 |
Exploring the prescribing trends and factors affecting initial anti-parkinsonian drug selection in Korea: A nationwide population-based cohort study.
Topics: Aged; Alzheimer Disease; Cohort Studies; Humans; Levodopa; Parkinson Disease; Peptic Ulcer; Republic of Korea | 2023 |
Palm Fruit Bioactives augment expression of Tyrosine Hydroxylase in the Nile Grass Rat basal ganglia and alter the colonic microbiome.
Topics: Alzheimer Disease; Animals; Basal Ganglia; Brain; Carbohydrates; Catalysis; Colon; Densitometry; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Gastrointestinal Microbiome; Gene Expression Regulation, Enzymologic; Humans; Hydroxylation; Immunohistochemistry; Levodopa; Male; Phoeniceae; Phytochemicals; Rats; Tyrosine; Tyrosine 3-Monooxygenase | 2019 |
l-Dopa and dopamine conjugated naphthalenediimides modulate amyloid β toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Dopamine; Drug Design; Humans; Imides; Levodopa; Molecular Docking Simulation; Naphthalenes; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Rats | 2018 |
Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).
Topics: Alzheimer Disease; Amino Acid Substitution; Antiparkinson Agents; Brain; Female; Humans; Levodopa; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Presenilin-1 | 2019 |
An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
Topics: Aged, 80 and over; Alzheimer Disease; Amphetamine; Dementia; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2014 |
Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dopamine Plasma Membrane Transport Proteins; Female; Geriatric Assessment; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2014 |
Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.
Topics: Acetylcholine; Afferent Pathways; Aged; Alzheimer Disease; Brain; CADASIL; Dopamine; Dopamine Agents; Evoked Potentials, Motor; Humans; Levodopa; Neural Inhibition; Transcranial Magnetic Stimulation | 2014 |
Hemiparkinsonism-hemiatrophy syndrome with Alzheimer's disease.
Topics: Alzheimer Disease; Antiparkinson Agents; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Positron-Emission Tomography; Syndrome | 2015 |
NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Disulfides; Drug Combinations; Galantamine; Humans; Levodopa; Plaque, Amyloid | 2015 |
L-dopa modulates motor cortex excitability in Alzheimer's disease patients.
Topics: Acetylcholine; Afferent Pathways; Aged; Aged, 80 and over; Alzheimer Disease; Cholinergic Agents; Dopamine; Dopamine Agents; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Middle Aged; Motor Cortex; Neural Inhibition; Neural Pathways; Nootropic Agents; Reaction Time; Synaptic Transmission; Time Factors; Transcranial Magnetic Stimulation | 2008 |
Acute dopamine depletion syndrome.
Topics: Aged; Alzheimer Disease; Confusion; Creatine Kinase; Dopamine; Dopamine Agents; Female; Fever; Humans; Hypothyroidism; Levodopa; Muscle Rigidity; Parkinson Disease | 2010 |
Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Data Interpretation, Statistical; Dopamine; Dopamine Agents; Electroencephalography; Evoked Potentials, Motor; Female; Humans; Levodopa; Long-Term Potentiation; Male; Motor Cortex; Neuronal Plasticity; Neuropsychological Tests; Synapses; Transcranial Magnetic Stimulation | 2011 |
Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.
Topics: alpha-Synuclein; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Cognition; Cognition Disorders; Diagnosis, Differential; Diagnostic Imaging; Frontotemporal Dementia; Genetic Markers; Genetic Testing; Glucosylceramidase; Humans; Huntington Disease; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Lewy Body Disease; Mutation; Parkinson Disease; Precision Medicine; Protein Serine-Threonine Kinases | 2013 |
Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Benserazide; Drug Combinations; Levodopa; Male; Memory; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neurotensin; Olfactory Bulb; Peptides; Rats; Rats, Wistar; Receptors, Muscarinic; Schizophrenia; Scopolamine; Space Perception | 2005 |
Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
Topics: Adult; Alzheimer Disease; Antiparkinson Agents; DNA Mutational Analysis; Dystonia; Family Health; GTP Cyclohydrolase; Humans; Iodine Isotopes; Levodopa; Male; Mutation; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Brain; Causality; Cerebral Amyloid Angiopathy; Cognition Disorders; Creatinine; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Predictive Value of Tests; Vitamin B 12 | 2005 |
[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
Topics: Alzheimer Disease; Antiparkinson Agents; Antipsychotic Agents; Austria; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Neuropsychological Tests | 2007 |
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Frontal Lobe; Hippocampus; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Nootropic Agents; Recognition, Psychology | 2009 |
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Butyrophenones; Dementia; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Phenothiazines; Phenylacetates | 1981 |
Chronic neurological diseases: their societal burdens and potential solutions.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Ataxia; Axons; Brain Diseases; Cerebral Cortex; Chronic Disease; Dopamine; Humans; Huntington Disease; Immunoglobulin G; Levodopa; Motor Neurons; Multiple Sclerosis; Parkinson Disease | 1980 |
Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Behavior; Circadian Rhythm; Confusion; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Psychomotor Agitation; Sleep, REM | 1995 |
Parkinson's dementia and Alzheimer's dementia: an evoked potential comparison.
Topics: Aged; Alzheimer Disease; Dementia; Evoked Potentials; Evoked Potentials, Visual; Humans; Levodopa; Mental Status Schedule; Parkinson Disease; Reaction Time; Regression Analysis | 1993 |
The clinical features of Parkinson's disease in 100 histologically proven cases.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Corpus Striatum; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Neurofibrillary Tangles; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Tissue Donors | 1993 |
A clinicopathologic study of 100 cases of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease; Survival Analysis | 1993 |
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E | 1995 |
Neurodegenerative disease: a different view of diagnosis.
Topics: Alzheimer Disease; Dementia; Dopamine Agents; Humans; Levodopa; Lewy Bodies; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Prion Diseases; Synucleins; tau Proteins | 1999 |
Transformation of beta-amyloid (A beta) (1-42) tyrosine to L-dopa as the result of in vitro hydroxyl radical attack.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chromatography, High Pressure Liquid; Humans; Hydroxyl Radical; Hydroxylation; Inflammation; Levodopa; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Tyrosine | 2000 |
[Elderly patients. Patients not fitting into a category are labeled as Alzheimer disease patients].
Topics: Aged; Alzheimer Disease; Diagnosis, Differential; Humans; Learning; Levodopa; Mental Recall; Stroke | 2001 |
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].
Topics: Aged; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebrovascular Disorders; Dementia; Digitalis Glycosides; Diuretics; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Psychoses, Substance-Induced | 1979 |
Exacerbation of parkinsonism by tacrine.
Topics: Aged; Alzheimer Disease; Electromyography; Female; Humans; Levodopa; Parkinson Disease; Tacrine | 1992 |
Neurotransmitter precursors and brain function.
Topics: Aged; Aging; Alzheimer Disease; Animals; Biological Transport; Brain; Diet; Humans; Learning; Levodopa; Memory; Neurotransmitter Agents; Parkinson Disease; Phosphatidylcholines; Serotonin; Sleep; Tryptophan | 1986 |
Familial Alzheimer's disease presenting as levodopa-responsive parkinsonism.
Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Inclusion Bodies; Levodopa; Parkinson Disease; Pedigree | 1987 |
A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
Topics: Aged; Alzheimer Disease; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamus; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1986 |
A woman with dementia and parkinsonism unresponsive to levodopa.
Topics: Alzheimer Disease; Brain; Dementia; Female; Humans; Levodopa; Middle Aged; Neurons; Parkinson Disease | 1988 |
Drug-induced alzheimerism.
Topics: Aged; Alzheimer Disease; Biperiden; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease; Piperidines | 1988 |
Pharmacology of mental aging and dementia disorders.
Topics: Acetylcholine; Aging; Alzheimer Disease; Dementia; Humans; Levodopa; Neuropeptides | 1987 |
[Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
Topics: Aged; Alzheimer Disease; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1985 |